Evidence map›Paper›PMID 31938449›Full record

ArticleInternational journal of clinical and experimental pathology2018

Epithelioid angiosarcoma of the liver: report of two cases and review of the literature.

Manmei Long, Wumairehan Shali, Qiongyi Huang, Yongyang Bao, Ying Chen, Yaming Rao, Henghua Zhou, Qiang Liu, Qiao He, Chuyi Zheng and 2 more

Open access · greenAbstract readCase Reports
PubMed Full text at PMC
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Primary epithelioid angiosarcoma of the liver.Clinical journal of gastroenterology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. [Analysis of clinicopathological features of 18 cases of hepatic angiosarcoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Manmei LongDepartment of Pathology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute Shanghai, China.
Wumairehan ShaliDepartment of General Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute Shanghai, China.
Qiongyi HuangDepartment of Pathology, Shanghai Tenth People's Hospital, Tongji University Shanghai, China.
Yongyang BaoDepartment of Pathology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute Shanghai, China.
Ying ChenDepartment of Pathology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute Shanghai, China.
Yaming RaoDepartment of Pathology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute Shanghai, China.
Henghua ZhouDepartment of Pathology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute Shanghai, China.
Qiang LiuDepartment of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China.
Qiao HeDepartment of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China.
Chuyi ZhengDepartment of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China.
Wenyong LiuDepartment of General Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute Shanghai, China.
Yanbo ZhuDepartment of Pathology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute Shanghai, China.
Renji Hospital · CNShanghai Jiao Tong University · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiosarcoma is a malignant tumor of endothelial origin. Epithelioid angiosarcoma is a subtype of angiosarcoma, in which the malignant endothelial cells have a predominantly epithelioid appearance. So far, few cases of primary hepatic epithelioid andiosarcoma (PHEA) have been described. In this case report, we describe two rare cases of PHEA. Microscopically, the tumors were consistently composed of atypical epithelioid cells with vesicular nuclei, prominent nucleoli, and eosinophilic cytoplasm. One patient had metastatic disease and underwent palliative hepatic surgery following radiotherapy and chemotherapy, and had a postoperative survival time of 12 months, while the other patient is still alive after tumor resection. PHEA is an aggressive malignant tumor with a high rate of metastasis.

Indexed as

Angiosarcomaepithelioid angiosarcomahepatmetastasis

Identifiers

PMID31938449
PMCPMC6958078
OpenAlexW3010060534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.